Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

The Impact of Systemic Lupus Erythematosus on the Risk of Newly Diagnosed Hip Fracture. A General Population-Based Study.

Li L, Xie H, Lu N, Esdaile JM, Aviña-Zubieta JA.

Arthritis Care Res (Hoboken). 2019 Nov 23. doi: 10.1002/acr.24112. [Epub ahead of print]

PMID:
31758639
2.

eHealth-supported decentralized multi-disciplinary care for gout involving rheumatology, pharmacy, and dietetics: proof-of-concept study.

Howren A, Tsao NW, Choi HK, Shojania K, Kydd A, Friesen R, Avina-Zubieta JA, De Vera MA.

Clin Rheumatol. 2019 Nov 13. doi: 10.1007/s10067-019-04809-6. [Epub ahead of print]

PMID:
31720913
3.

Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study.

Yokose C, Lu N, Xie H, Li L, Zheng Y, McCormick N, Rai SK, Aviña-Zubieta JA, Choi HK.

CMAJ. 2019 Sep 30;191(39):E1070-E1077. doi: 10.1503/cmaj.190339.

4.

Trends of venous thromboembolism risk before and after diagnosis of gout: a general population-based study.

Li L, McCormick N, Sayre EC, Esdaile JM, Lacaille D, Xie H, Choi HK, Aviña-Zubieta JA.

Rheumatology (Oxford). 2019 Sep 19. pii: kez398. doi: 10.1093/rheumatology/kez398. [Epub ahead of print]

PMID:
31535692
5.

Defining depression and anxiety in individuals with rheumatic diseases using administrative health databases: A systematic review.

Howren A, Avina-Zubieta JA, Puyat JH, Esdaile JM, Da Costa D, De Vera MA.

Arthritis Care Res (Hoboken). 2019 Aug 17. doi: 10.1002/acr.24048. [Epub ahead of print]

PMID:
31421021
6.

Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review.

Huang K, Vinik O, Shojania K, Yeung J, Shupak R, Nimmo M, Avina-Zubieta JA.

Rheumatol Int. 2019 Nov;39(11):1971-1981. doi: 10.1007/s00296-019-04398-2. Epub 2019 Aug 2. Review.

PMID:
31375890
7.

Socioeconomic status at diagnosis influences the incremental direct medical costs of systemic lupus erythematosus: A longitudinal population-based study.

McCormick N, Marra CA, Sadatsafavi M, Aviña-Zubieta JA.

Semin Arthritis Rheum. 2019 Jun 14. pii: S0049-0172(18)30146-X. doi: 10.1016/j.semarthrit.2019.06.010. [Epub ahead of print]

PMID:
31358362
8.

Patterns of medication use before, during and after pregnancy in women with systemic lupus erythematosus: a population-based cohort study.

Zusman EZ, Sayre EC, Aviña-Zubieta JA, De Vera MA.

Lupus. 2019 Sep;28(10):1205-1213. doi: 10.1177/0961203319863111. Epub 2019 Jul 16.

PMID:
31311418
9.

How do patients with systemic autoimmune rheumatic disease perceive the use of their medications: a systematic review and thematic synthesis of qualitative research.

Haag H, Liang T, Avina-Zubieta JA, De Vera MA.

BMC Rheumatol. 2018 Apr 2;2:9. doi: 10.1186/s41927-018-0017-8. eCollection 2018.

10.

Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study.

Aviña-Zubieta JA, Chan J, De Vera M, Sayre EC, Choi H, Esdaile J.

Ann Rheum Dis. 2019 Apr;78(4):480-485. doi: 10.1136/annrheumdis-2018-214388. Epub 2019 Feb 8.

PMID:
30737222
11.

Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data.

Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A, Carroll MW, Hazlewood G, Jacobson K, Jelinski S, Deardon R, Jones JL, Kuenzig ME, Leddin D, McBrien KA, Murthy SK, Nguyen GC, Otley AR, Panaccione R, Rezaie A, Rosenfeld G, Peña-Sánchez JN, Singh H, Targownik LE, Kaplan GG.

Gastroenterology. 2019 Apr;156(5):1345-1353.e4. doi: 10.1053/j.gastro.2019.01.002. Epub 2019 Jan 10.

12.

Exploring strategies to support medication adherence in patients with inflammatory arthritis: a patient-oriented qualitative study using an interactive focus group activity.

Rai SK, Howren A, Wilcox ES, Townsend AF, Marra CA, Aviña-Zubieta JA, De Vera MA.

Patient Prefer Adherence. 2018 Oct 5;12:2015-2025. doi: 10.2147/PPA.S174672. eCollection 2018.

13.

Using Physical Activity Trackers in Arthritis Self-Management: A Qualitative Study of Patient and Rehabilitation Professional Perspectives.

Leese J, Macdonald GG, Tran BC, Wong R, Backman CL, Townsend AF, Davis AM, Jones CA, Gromala D, Avina-Zubieta JA, Hoens AM, Li LC.

Arthritis Care Res (Hoboken). 2019 Feb;71(2):227-236. doi: 10.1002/acr.23780.

PMID:
30295430
14.

Asthma is not associated with the need for surgery in Crohn's disease when controlling for smoking status: a population-based cohort study.

Kuenzig ME, Sadatsafavi M, Aviña-Zubieta JA, Burne RM, Abrahamowicz M, Beauchamp ME, Kaplan GG, Benchimol EI.

Clin Epidemiol. 2018 Jul 12;10:831-840. doi: 10.2147/CLEP.S156772. eCollection 2018.

15.

Cardiovascular Disease Prevention in Rheumatoid Arthritis: Compliance with Diabetes Screening Guidelines.

Schmidt TJ, Aviña-Zubieta JA, Sayre EC, Abrahamowicz M, Esdaile JM, Lacaille D.

J Rheumatol. 2018 Oct;45(10):1367-1374. doi: 10.3899/jrheum.170973. Epub 2018 Jul 15.

PMID:
30008457
16.

Quality of care for cardiovascular disease prevention in rheumatoid arthritis: compliance with hyperlipidemia screening guidelines.

Schmidt TJ, Aviña-Zubieta JA, Sayre EC, Abrahamowicz M, Esdaile JM, Lacaille D.

Rheumatology (Oxford). 2018 Oct 1;57(10):1789-1794. doi: 10.1093/rheumatology/key164.

PMID:
29955871
17.

All-Cause and Cause-Specific Mortality in Patients With Granulomatosis With Polyangiitis: A Population-Based Study.

Tan JA, Choi HK, Xie H, Sayre EC, Esdaile JM, Aviña-Zubieta JA.

Arthritis Care Res (Hoboken). 2019 Jan;71(1):155-163. doi: 10.1002/acr.23587.

PMID:
29692001
18.

Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: A general population-based study.

McCormick N, Marra CA, Sadatsafavi M, Aviña-Zubieta JA.

Lupus. 2018 Jul;27(8):1247-1258. doi: 10.1177/0961203318768882. Epub 2018 Apr 17.

PMID:
29665755
19.

Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population-Based Study.

McCormick N, Marra CA, Sadatsafavi M, Kopec JA, Aviña-Zubieta JA.

Arthritis Care Res (Hoboken). 2019 Jan;71(1):142-154. doi: 10.1002/acr.23573.

PMID:
29648677
20.

IL-6 expression is correlated with increased T-cell proliferation and survival in the arterial wall in giant cell arteritis.

Manku S, Wong W, Luo Z, Seidman MA, Alabdurubalnabi Z, Rey K, Enns W, Avina-Zubieta JA, Shojania K, Choy JC.

Cardiovasc Pathol. 2018 Mar - Apr;33:55-61. doi: 10.1016/j.carpath.2018.01.004. Epub 2018 Jan 9.

PMID:
29414433
21.

Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.

McCormick N, Marra CA, Aviña-Zubieta JA.

Curr Rheumatol Rep. 2017 Oct 30;19(11):72. doi: 10.1007/s11926-017-0698-9. Review.

PMID:
29086172
22.

Risk of Incident Chronic Obstructive Pulmonary Disease in Rheumatoid Arthritis: A Population-Based Cohort Study.

Mcguire K, Aviña-Zubieta JA, Esdaile JM, Sadatsafavi M, Sayre EC, Abrahamowicz M, Lacaille D.

Arthritis Care Res (Hoboken). 2019 May;71(5):602-610. doi: 10.1002/acr.23410. Epub 2018 Apr 2.

PMID:
29047218
23.

Response to: 'Mortality in ANCA-associated vasculitis: mission incomplete' by Moiseev et al.

Avina-Zubieta JA, Dehghan N, Tan JA.

Ann Rheum Dis. 2018 Feb;77(2):e9. doi: 10.1136/annrheumdis-2017-211792. Epub 2017 Jul 14. No abstract available.

PMID:
28710096
25.

Mortality in ANCA-associated vasculitis: ameta-analysis of observational studies.

Tan JA, Dehghan N, Chen W, Xie H, Esdaile JM, Avina-Zubieta JA.

Ann Rheum Dis. 2017 Sep;76(9):1566-1574. doi: 10.1136/annrheumdis-2016-210942. Epub 2017 May 3.

PMID:
28468793
26.

Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A Population-based Case-Control Study.

Kuenzig ME, Barnabe C, Seow CH, Eksteen B, Negron ME, Rezaie A, Panaccione R, Benchimol EI, Sadatsafavi M, Aviña-Zubieta JA, Kaplan GG.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1405-1412.e3. doi: 10.1016/j.cgh.2017.02.042. Epub 2017 Mar 23.

27.

The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary Sjögren Syndrome: A General Population-based Study.

Aviña-Zubieta JA, Jansz M, Sayre EC, Choi HK.

J Rheumatol. 2017 Aug;44(8):1184-1189. doi: 10.3899/jrheum.160185. Epub 2017 Mar 15.

28.

Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study.

Aviña-Zubieta JA, To F, Vostretsova K, De Vera M, Sayre EC, Esdaile JM.

Arthritis Care Res (Hoboken). 2017 Jun;69(6):849-856. doi: 10.1002/acr.23018. Epub 2017 May 9.

29.

The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.

Rai SK, Aviña-Zubieta JA, McCormick N, De Vera MA, Shojania K, Sayre EC, Choi HK.

Semin Arthritis Rheum. 2017 Feb;46(4):451-456. doi: 10.1016/j.semarthrit.2016.08.006. Epub 2016 Aug 17.

30.

Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap.

Lacaille D, Avina-Zubieta JA, Sayre EC, Abrahamowicz M.

Ann Rheum Dis. 2017 Jun;76(6):1057-1063. doi: 10.1136/annrheumdis-2016-209562. Epub 2016 Dec 28.

31.

Risk of Myocardial Infarction and Stroke in Patients With Granulomatosis With Polyangiitis (Wegener's): A Population-Based Study.

Aviña-Zubieta JA, Mai A, Amiri N, Dehghan N, Ann Tan J, Sayre EC, Choi HK.

Arthritis Rheumatol. 2016 Nov;68(11):2752-2759. doi: 10.1002/art.39762. Epub 2016 Sep 29.

32.

Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada From 2000 to 2011.

Rai SK, Aviña-Zubieta JA, McCormick N, De Vera MA, Lacaille D, Sayre EC, Choi HK.

Arthritis Care Res (Hoboken). 2017 May;69(5):758-762. doi: 10.1002/acr.23012.

33.

Improved survival in rheumatoid arthritis: a general population-based cohort study.

Zhang Y, Lu N, Peloquin C, Dubreuil M, Neogi T, Aviña-Zubieta JA, Rai SK, Choi HK.

Ann Rheum Dis. 2017 Feb;76(2):408-413. doi: 10.1136/annrheumdis-2015-209058. Epub 2016 Jun 23.

34.

Early Cardiovascular Disease After the Diagnosis of Systemic Sclerosis.

Aviña-Zubieta JA, Man A, Yurkovich M, Huang K, Sayre EC, Choi HK.

Am J Med. 2016 Mar;129(3):324-31. doi: 10.1016/j.amjmed.2015.10.037. Epub 2015 Nov 19.

PMID:
26603342
35.

Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study.

Rai SK, Choi HK, Sayre EC, Aviña-Zubieta JA.

Rheumatology (Oxford). 2016 Mar;55(3):461-9. doi: 10.1093/rheumatology/kev336. Epub 2015 Sep 30.

PMID:
26424835
36.

The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study.

Aviña-Zubieta JA, Vostretsova K, De Vera MA, Sayre EC, Choi HK.

Semin Arthritis Rheum. 2015 Oct;45(2):195-201. doi: 10.1016/j.semarthrit.2015.05.008. Epub 2015 May 19.

37.

Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review.

McCormick N, Bhole V, Lacaille D, Avina-Zubieta JA.

PLoS One. 2015 Aug 20;10(8):e0135834. doi: 10.1371/journal.pone.0135834. eCollection 2015.

38.

Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study.

Amiri N, De Vera M, Choi HK, Sayre EC, Avina-Zubieta JA.

Rheumatology (Oxford). 2016 Jan;55(1):33-40. doi: 10.1093/rheumatology/kev262. Epub 2015 Aug 5.

PMID:
26248811
39.

Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study.

Schoenfeld SR, Choi HK, Sayre EC, Aviña-Zubieta JA.

Arthritis Care Res (Hoboken). 2016 Feb;68(2):246-53. doi: 10.1002/acr.22673.

40.

Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process.

Barber CE, Marshall DA, Alvarez N, Mancini GB, Lacaille D, Keeling S, Aviña-Zubieta JA, Khodyakov D, Barnabe C, Faris P, Smith A, Noormohamed R, Hazlewood G, Martin LO, Esdaile JM; Quality Indicator International Panel.

J Rheumatol. 2015 Sep;42(9):1548-55. doi: 10.3899/jrheum.141603. Epub 2015 Jul 15.

41.

Approaches for estimating minimal clinically important differences in systemic lupus erythematosus.

Rai SK, Yazdany J, Fortin PR, Aviña-Zubieta JA.

Arthritis Res Ther. 2015 Jun 3;17:143. doi: 10.1186/s13075-015-0658-6. Review.

42.

A systematic review identifies valid comorbidity indices derived from administrative health data.

Yurkovich M, Avina-Zubieta JA, Thomas J, Gorenchtein M, Lacaille D.

J Clin Epidemiol. 2015 Jan;68(1):3-14. doi: 10.1016/j.jclinepi.2014.09.010. Epub 2014 Oct 31. Review.

PMID:
25441702
43.

Response to: 'Venous thromboembolic events in systemic vasculitis' by Novikov et al.

Aviña-Zubieta JA, Bhole VM, Amiri N, Sayre EC, Choi HK.

Ann Rheum Dis. 2015 Mar;74(3):e28. doi: 10.1136/annrheumdis-2014-206853. Epub 2014 Nov 25. No abstract available.

PMID:
25425544
44.

The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.

Aviña-Zubieta JA, Bhole VM, Amiri N, Sayre EC, Choi HK.

Ann Rheum Dis. 2016 Jan;75(1):148-54. doi: 10.1136/annrheumdis-2014-205665. Epub 2014 Sep 29.

45.

Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study.

Carruthers EC, Choi HK, Sayre EC, Aviña-Zubieta JA.

Ann Rheum Dis. 2016 Jan;75(1):110-6. doi: 10.1136/annrheumdis-2014-205800. Epub 2014 Sep 5.

46.

Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis.

McCormick N, Lacaille D, Bhole V, Avina-Zubieta JA.

PLoS One. 2014 Aug 15;9(8):e104519. doi: 10.1371/journal.pone.0104519. eCollection 2014. Review.

47.

Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators.

Barber CE, Smith A, Esdaile JM, Barnabe C, Martin LO, Faris P, Hazlewood G, Noormohamed R, Alvarez N, Mancini GB, Lacaille D, Keeling S, Aviña-Zubieta JA, Marshall D.

Arthritis Care Res (Hoboken). 2015 Feb;67(2):169-79. doi: 10.1002/acr.22419. Review.

48.

Validity of myocardial infarction diagnoses in administrative databases: a systematic review.

McCormick N, Lacaille D, Bhole V, Avina-Zubieta JA.

PLoS One. 2014 Mar 28;9(3):e92286. doi: 10.1371/journal.pone.0092286. eCollection 2014.

49.

Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces.

Broten L, Aviña-Zubieta JA, Lacaille D, Joseph L, Hanly JG, Lix L, O'Donnell S, Barnabe C, Fortin PR, Hudson M, Jean S, Peschken C, Edworthy SM, Svenson L, Pineau CA, Clarke AE, Smith M, Bélisle P, Badley EM, Bergeron L, Bernatsky S.

J Rheumatol. 2014 Apr;41(4):673-9. doi: 10.3899/jrheum.130667. Epub 2014 Mar 1.

PMID:
24584928
50.

The needs of persons with lupus and health care providers: a qualitative study aimed toward the development of the Lupus Interactive Navigator™.

Neville C, Da Costa D, Mill C, Rochon M, Aviña-Zubieta JA, Pineau CA, Eng D, Fortin PR.

Lupus. 2014 Feb;23(2):176-82. doi: 10.1177/0961203313517154. Epub 2013 Dec 13.

PMID:
24335012

Supplemental Content

Loading ...
Support Center